Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial

Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial

Introduction and Objectives: Some studies suggest chronic HCV infection diminishes responses to the anti-HBV vaccine. We evaluated the efficacy of double versus standard dose HBV vaccination among HCV patients without cirrhosis. Patients and Methods: 141 adults with untreated chronic HCV were random...

Full description

Bibliographic Details
Main Authors: Roseane P. Medeiros, Norah A. Terrault, Daniel F. Mazo, Claudia P. Oliveira, Jennifer Dodge, Patricia M. Zitelli, Marta H. Lopes, Flair J. Carrilho, Mário G. Pessoa
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Annals of Hepatology
Subjects:
Seroprotection
Fibrosis
Immunization
Prevention
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268122002332

Internet

http://www.sciencedirect.com/science/article/pii/S1665268122002332

Similar Items